TriSalus Life Sciences (TLSIW) Total Debt (2022 - 2026)

TriSalus Life Sciences (TLSIW) has 5 years of Total Debt data on file, last reported at $33.1 million in Q1 2026.

• For the quarter ending Q1 2026, Total Debt rose 4.35% year-over-year to $33.1 million; the trailing twelve-month figure through Mar 2026 stood at $33.1 million (up 4.35% YoY), and the FY2025 full-year result was $33.0 million, up 49.64% from the prior year.
• Total Debt for Q1 2026 stood at $33.1 million, roughly flat from $33.0 million in the prior quarter.
• Across five years, Total Debt topped out at $33.1 million in Q1 2026 and bottomed at $2.5 million in Q4 2022.
• The 5-year median for Total Debt is $22.1 million (2024), against an average of $22.3 million.
• The widest annual swing landed in 2024, when Total Debt jumped 111.86%; it then increased 4.35% in 2026.
• A 5-year view of Total Debt shows it stood at $2.5 million in 2022, then soared by 309.75% to $10.0 million in 2023, then soared by 119.81% to $22.1 million in 2024, then jumped by 49.64% to $33.0 million in 2025, then climbed by 0.1% to $33.1 million in 2026.
• The last three Total Debt figures came in at $33.1 million (Q1 2026), $33.0 million (Q4 2025), and $32.8 million (Q3 2025), per Business Quant data.

Peer Comparison